Sentences with phrase «deals with biotech companies»

What's more, this is only the first of 10 similar deals with biotech companies, according to the outlet.

Cuomo called the state's $ 200 million deal with the biotech company Athenex «a game - changer for Dunkirk.»

Not exact matches

Andrew Olsen writes: I was struck by the contrast between how established biotech and pharmaceutical companies have dealt with this problem vs. what you described in your 6 step process.

The company just announced a lucrative deal with the biotech firm Genetech, and says many similar deals are in the works.

Indeed, biotechs and other tech companies led deal flow, says Renaissance, with 13 and 10 IPOs being staged, respectively.

The difficulties that many biotech companies are facing at present have to be dealt with in a professional manner, he stresses, and points out that most biotech companies in Germany receive neither support nor guidance in tricky times.

It paid $ 30 million for access to the RNA interference know - how and patents held by the biotech company Alnylam, and it did a similar deal with Tekmira, an RNA delivery specialist based in Burnaby, British Columbia.

Despite being the result of public research, golden rice is enmeshed in around seventy patents owned by some thirty - two companies and institutions, according to the US - based International Service for the Acquisition of Agri - biotech Applications (ISAAA).4 Because of the complexity of licensing arrangements, the inventors ceded their rights to Greenovation, a biotech spin - off company from the University of Freiburg, which then struck a deal with AstraZeneca (now Syngenta).

In the past 5 years or so, there have been two or three deals with pharma and biotech companies that have been anywhere from 500 MM to 2 Billion dollars.

And, very locally: I let my IT flag fly a little bit while responding to a Capital Rants post about physical headquarters versus virtual operations, a question biotech and pharma companies actually deal with a lot, given the incredible range of service providers to the industry; and I went to a planning meeting for Ontario's presence at BIO2009 in Atlanta (hint: cool pavilion, free coffee).

Indeed, biotechs and other tech companies led deal flow, says Renaissance, with 13 and 10 IPOs being staged, respectively.